**Acknowledgements**

We would like to thank our partner institutions, which provided technical support to develop our clinical studies on tropical diseases, in special the Hospital São José de Doenças Infecciosas, Centro de Assistência Toxicológica do Instituto Dr. José Frota, Hospital Geral de Fortaleza, Hospital Universitário Walter Cantídio, and the Edson Queiroz Foundation/University of Fortaleza. We also thank the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for providing research grants for our group (GBSJ and EFD—bolsistas de produtividade em pesquisa, PQ-2), and the Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico—FUNCAP, which supports the research on novel kidney injury biomarkers for our study group (edital PPSUS 01/2017).

[5] Vinhaes MC, Dias JCD. Chagas disease in Brazil. Cad Saúde Pública (Rio de Janeiro).

Neglected Tropical Diseases with an Impact on Kidney Function

http://dx.doi.org/10.5772/intechopen.78981

41

[6] Dias JCP, Ramos Junior AN, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. II Consenso Brasileiro em Doença de Chagas, 2015. Epidemiologia e Serviços

[7] Maguire JH. Trypanosoma. In: Gorbach S, Bartlett J, Blacklow N, editors. Infectious Diseases. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2004. pp. 2327-2334 [8] Teixeira ARL, Nascimento R, Sturm NR. Evolution and pathology in Chagas disease— A review. Memórias do Instituto Oswaldo Cruz. 2006;**101**:463-491. DOI: 10.1590/

[9] Costa RS, Monteiro RC, Lehuen A, Joskowicz M, Noël LH, Droz D. Immune complexmediated glomerulopathy in experimental Chagas' disease. Clinical Immunology and

[10] Oliveira GM, Masuda MO, Rocha NN, Schor N, Hooper CS, Araújo-Jorge TC, Henriques-Pons A. Absence of Fas-L aggravates renal injury in acute *Trypanosoma cruzi* infection. Memórias do Instituto Oswaldo Cruz. 2009;**104**:1063-1071. DOI: 10.1590/S0074-02762009000

[11] Cumbinho LC, Pizzini CC, Oliveira FS, Batista W, Oliveira GM. Cardiorenal interaction during the acute phase of experimental *Trypanosoma cruzi* infection: The influence of aldosteron and the AT1 receptor on mortality. Journal of Experimental and Integrative

[12] Lemos JRD, Rodrigues WF, Miguel CB, Parreira RC, Miguel RB, Rogerio AP, et al. Influence of parasite load on renal function in mice acutely infected with *Trypanosoma* 

[13] Oliveira GM, da Silva TM, Batista WS, Franco M, Schor N. Acute *Trypanosoma cruzi* experimental infection induced renal ischemic/reperfusion lesion in mice. Parasitology

[14] Bruijn JA, Oemar BS, Ehrich JH, Oemar BS, Ehrich JM.Anti-basement membrane glomerulopathy in experimental trypanosomiasis. Journal of Immunology. 1987;**139**:2482-2488

[15] Van Velthuysen MLF, Bruijn JA, Van Leer EHG, Fleuren GJ. Pathogenesis of trypanosomiasis-induced glomerulonephritis in mice. Nephrology, Dialysis, Transplantation.

[16] Rickman WJ, Cox HW. Association of autoantibodies with anemia, splenomegaly, and glomerulonephritis in experimental African trypanosomiasis. The Journal of Parasito-

[17] Tarleton RL. Chagas disease: A role for autoimmunity? Trends in Parasitology. 2003;

Immunopathology. 1991;**58**:102-114. DOI: 10.1016/0090-1229(91)90152-Z

Medicine. 2012;**2**:199-206. DOI: 10.5455/jeim.070512.or.029

Research. 2009;**106**:111-120. DOI: 10.1371/journal.pone.0071772

2000;**16**:7-12. DOI: 10.1590/S0102-311X2000000800002

S0074-02762006000500001

*cruzi*. PLoS One. 2013;**8**:e71772

1992;**7**:507-515

logy. 1979;**65**:65-73

**19**:447-451. DOI: 10.1016/j.pt.2003.08.008

800002

de Saúde. 2016;**25**:7-86. DOI: 10.5123/s1679-49742016000500002
